Trial intelligence / Profile preview

Ziprasidone vs Aripiprazole in Schizophrenia with Metabolic Syndrome

NCT01714011Phase 4Completed

Sponsor
Universiti Malaya
Start
May 2009
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziprasidone in schizophrenia, sponsored by Universiti Malaya. Started May 2009; status: completed.

02

Drugs

ziprasidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01714011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01714011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call